Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB3 | P13945 | 1/20 | 0.39 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.39 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13798435 | 1.00 | ADRB3 (0.39) | ADRB3ADRA2BADRA2CCYP3A4 | |
| SCHEMBL13798425 | 0.94 | ADRB3 (0.39) | ADRB3ADRA2BADRA2CCYP3A4 | |
| SCHEMBL8179866 | 0.93 | ADRB3 (0.38) | ADRB3ADRA2BADRA2CCYP3A4 | |
| SCHEMBL13435889 | 0.93 | ADRB3 (0.40) | ADRB3ADRA2BADRA2CCYP3A4 | |
| SCHEMBL8183894 | 0.93 | ADRB3 (0.38) | ADRB3ADRA2BADRA2CCYP3A4 | |
| SCHEMBL13798439 | 0.92 | ADRB3 (0.38) | ADRB3ADRA2BADRA2CCYP3A4 | |
| SCHEMBL13435827 | 0.92 | ADRB3 (0.38) | ADRB3ADRA2BADRA2CCYP3A4 | |
| SCHEMBL13435936 | 0.92 | ADRB3 (0.38) | ADRB3ADRA2BADRA2CCYP3A4 | |
| SCHEMBL13436022 | 0.92 | DDB1 (0.31) | ADRB3ADRA2BADRA2C | |
| SCHEMBL13435963 | 0.91 | ADRB3 (0.38) | ADRB3ADRA2BADRA2CCYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2177523-A1 | Novel macrocyclic inhibitors of hepatitis c virus replication | Intermune, Inc. (US) | 2010-04-21 | — | — | EP | disclosed |